SectorPharmaceutical
Established Date01/06/2022
Listing Date12/07/2023
ExchangeNASDAQ Stock Exchange
Full-time Employees3
Fiscal Year Ends31/12
Security TypeCommon stock
Office address1025 Connecticut Avenue NW Suite 1000 Washington, D.C. 20036
Business
Introduction60 Degrees Pharmaceuticals, Inc., was incorporated in Delaware on June 1, 2022 after merging with a limited liability company of the same name. The Company is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of infectious diseases. Its product Arakoda (a malaria preventive drug) has been on the market since 2019, and its R&D pipeline also includes other vector, fungal and viral disease projects.
